Pharmaceutical / Drug Definition :
Inhibits calcium transport into myocardial and vascular smooth muscle cells, suppressing contractions. Dilates main coronary arteries and arterioles, inhibits coronary artery spasm, increases oxygen delivery to heart, and reduces frequency and severity of angina attacks.
In the United States, Nitroglycerin is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Nitroglycerin.
FDA Label Requirements and Exceptions
FDA Import Information
Nitroglycerin (Nitroglycerin Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Nitroglycerin (Nitroglycerin Suppliers)
- Processors Nitroglycerin
- Repackers Nitroglycerin
- Relabelers Nitroglycerin
- Exporters Nitroglycerin
- Importers Nitroglycerin
For more information about Nitroglycerin, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.